A clinical study to compare effect of madhughrita pratisaran with calcium dobesilate in management of raktarsha(bleeding piles)

A randomized comparative clinical trial to evaluate the efficacy of madhughrita pratisaran with calcium dobesilate in raktarsha

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025259

Enrollment

Registered

2020-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K648- Other hemorrhoids

Interventions

Intervention1: Madhughrita pratisaran: Group A will be treated with madhughrita pratisaran daily for 7 days with follow up on 3rd, 5th, 7th day Control Intervention1: Calcium dobesilate: Group B will

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age between 20-50 yrs 2 Both male and female and others 3 patients with 1st 2nd, 3rd degree haemorrhoids 4 bleeding piles

Exclusion criteria

Exclusion criteria: 1 Prolapsed of the rectum 2 k/c/o Fistula in ano 3 perineal Abscess 4 k/c/o Malignancy 5 K/C/O Crohns disease 6 K/C/O Ulcerative colitis 7 Rectal polyp 8 K/C/O Diverticulitis 9 K/C/O Hypertension 10 Bleeding Disorders 11 Hb % less than 7 gm%

Design outcomes

Primary

Measure	Time frame
To compare efficacy of Madhughrita Pratisaran and Calcium dobesilate applied locally thrice a day for 7 days in the management of Raktarsha.Timepoint: 7 days with follow up on 3rd, 5th and 7th day	—

Secondary

Measure	Time frame
To study the adverse effect of Madhughrita Pratisaran if anyTimepoint: 7 days with follow up on 3rd, 5th and 7th day	—

Countries

India

Contacts

Public ContactNutan Valmik Sanap

PDEAS College of ayurved and research centre

drbharat_oza@yahoo.co.in9970254593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026